{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:32Z","timestamp":1793395652805,"version":"4.5.0"},"reference-count":230,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001332","name":"Council for Scientific and Industrial Research, South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/0591(16126)\/2022-EMR-I"],"award-info":[{"award-number":["09\/0591(16126)\/2022-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioadv.2026.214822","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:26:00Z","timestamp":1773829560000},"page":"214822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Emerging role of cell membrane-coated nanoparticles in targeted therapy for brain disorders"],"prefix":"10.1016","volume":"184","author":[{"given":"Vaishnavi","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Shahrukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahkashan","family":"Jabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiya","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazeer","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan Jalees","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2026.214822_bb0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2020.02.015","article-title":"Nanocarrier-mediated brain delivery of bioactives for treatment\/prevention of neurodegenerative diseases","volume":"321","author":"Babazadeh","year":"2020","journal-title":"J. Control. Release"},{"issue":"33","key":"10.1016\/j.bioadv.2026.214822_bb0010","doi-asserted-by":"crossref","first-page":"35223","DOI":"10.1021\/acsomega.4c01774","article-title":"Current overview on the use of nanosized drug delivery systems in the treatment of neurodegenerative diseases","volume":"9","author":"Ozceylan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioadv.2026.214822_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112117","article-title":"Nanotechnology-based drug delivery for central nervous system disorders","volume":"143","author":"Nguyen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214822_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70120","article-title":"Management of Alzheimer\u2019s disease with nanotechnological interventions and novel therapeutics","volume":"86","author":"Shahrukh","year":"2025","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-023-01854-3","article-title":"Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches","volume":"22","author":"Hasan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioadv.2026.214822_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113893","article-title":"Biomembrane camouflaged nanoparticles: a paradigm shifts in targeted drug delivery system","volume":"238","author":"Qureshi","year":"2024","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2026.214822_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104555","article-title":"Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and resveratrol to Alzheimer\u2019s disease: synthesis, in vitro characterization and brain uptake analysis","volume":"86","author":"Jain","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-023-02004-z","article-title":"Cell membrane-based nanomaterials for theranostics of central nervous system diseases","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb0050","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1039\/D0BM01164A","article-title":"Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioadv.2026.214822_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2023.06.023","article-title":"Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: insights and challenges","volume":"360","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214822_bb0060","doi-asserted-by":"crossref","unstructured":"X. Niu, J. Chen, J. G.-A. 2019, \u201cNanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: focus on recent advances,\u201d Asian J. Pharm. Sci. 2019\u2022Elsevier.","DOI":"10.1016\/j.ajps.2018.09.005"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","article-title":"Transport of drugs across the blood\u2013brain barrier by nanoparticles","volume":"161","author":"Wohlfart","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214822_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105612","article-title":"Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases","volume":"170","author":"Nguyen-Thi","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioadv.2026.214822_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/7355_2013_22","article-title":"Nanoparticles as blood\u2013brain barrier permeable CNS targeted drug delivery systems","volume":"10","author":"Grabrucker","year":"2013","journal-title":"Topics Med. Chem."},{"key":"10.1016\/j.bioadv.2026.214822_bb0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming blood\u2013brain barrier transport: advances in nanoparticle-based drug delivery strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Mater. Today"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214822_bb0085","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbadis.2015.10.014","article-title":"Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease","volume":"1862","author":"Simon","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioadv.2026.214822_bb0090","doi-asserted-by":"crossref","unstructured":"K. H. Narsinh et al., \u201cStrategies to improve drug delivery across the blood\u2013brain barrier for glioblastoma,\u201d Curr. Neurol. Neurosci. Reports 2024 245, vol. 24, no. 5, pp. 123\u2013139, Apr. 2024, doi:https:\/\/doi.org\/10.1007\/S11910-024-01338-X, Curr. Neurol. Neurosci. Rep.","DOI":"10.1007\/s11910-024-01338-x"},{"key":"10.1016\/j.bioadv.2026.214822_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121790","article-title":"\u2018Nanodecoys\u2019 - future of drug delivery by encapsulating nanoparticles in natural cell membranes","volume":"621","author":"Imran","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"26","key":"10.1016\/j.bioadv.2026.214822_bb0100","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1039\/D0TB00472C","article-title":"Cell membrane-engineered hybrid soft nanocomposites for biomedical applications","volume":"8","author":"Li","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"10","key":"10.1016\/j.bioadv.2026.214822_bb0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/iub.106","article-title":"Erythrocyte programmed cell death","volume":"60","author":"F\u00f6ller","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bioadv.2026.214822_bb0110","doi-asserted-by":"crossref","unstructured":"Y. Godfrin et al., \u201cInternational seminar on the red blood cells as vehicles for drugs,\u201d Expert. Opin. Biol. Ther., vol. 12, no. 1, pp. 127\u2013133, Jan. 2012, doi:https:\/\/doi.org\/10.1517\/14712598.2012.631909\/ASSET\/\/CMS\/ASSET\/4FD7960C-A4B1-4A2B-9599-8F0A019F72B5\/14712598.2012.631909.FP.PNG.","DOI":"10.1517\/14712598.2012.631909"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0115","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/acsbiomaterials.8b01557","article-title":"Therapy for gastric Cancer with peritoneal metastasis using injectable albumin hydrogel hybridized with paclitaxel-loaded red blood cell membrane nanoparticles","volume":"5","author":"Qian","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioadv.2026.214822_bb0120","doi-asserted-by":"crossref","unstructured":"P. A. Oldenborg, A. Zheleznyak, Y. F. Fang, C. F. Lagenaur, H. D. Gresham, and F. P. Lindberg, \u201cRole of CD47 as a marker of self on red blood cells,\u201d Science (80-. )., vol. 288, no. 5473, pp. 2051\u20132054, Jun. 2000, doi:https:\/\/doi.org\/10.1126\/SCIENCE.288.5473.2051.","DOI":"10.1126\/science.288.5473.2051"},{"key":"10.1016\/j.bioadv.2026.214822_bb0125","doi-asserted-by":"crossref","first-page":"563938","DOI":"10.3389\/fonc.2020.563938","article-title":"Dual-target peptide-modified erythrocyte membrane-enveloped PLGA nanoparticles for the treatment of glioma","volume":"10","author":"Cui","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214822_bb0130","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acsnano.8b00477","article-title":"Bioengineered Boronic Ester modified dextran polymer nanoparticles as reactive oxygen species responsive Nanocarrier for ischemic stroke treatment","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-019-0494-y","article-title":"Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery","volume":"17","author":"Wang","year":"2019","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0140","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/nn405724x","article-title":"Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy","volume":"8","author":"Gujrati","year":"2014","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bioadv.2026.214822_bb0150","doi-asserted-by":"crossref","unstructured":"J. R. Fitzgerald, T. J. Foster, and D. Cox, \u201cThe interaction of bacterial pathogens with platelets,\u201d Nat. Rev. Microbiol. 2006 46, vol. 4, no. 6, pp. 445\u2013457, Jun. 2006, doi:https:\/\/doi.org\/10.1038\/nrmicro1425.","DOI":"10.1038\/nrmicro1425"},{"key":"10.1016\/j.bioadv.2026.214822_bb0155","doi-asserted-by":"crossref","unstructured":"M. R. Yeaman, \u201cPlatelets in defense against bacterial pathogens,\u201d Cell. Mol. Life Sci. 2009 674, vol. 67, no. 4, pp. 525\u2013544, Dec. 2009, doi:https:\/\/doi.org\/10.1007\/S00018-009-0210-4.","DOI":"10.1007\/s00018-009-0210-4"},{"issue":"11","key":"10.1016\/j.bioadv.2026.214822_bb0160","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1538-7836.2009.03586.x","article-title":"Platelet functions beyond hemostasis","volume":"7","author":"Smyth","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bioadv.2026.214822_bb0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.progpolymsci.2015.02.004","article-title":"Advancing biomaterials of human origin for tissue engineering","volume":"53","author":"Chen","year":"2016","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.bioadv.2026.214822_bb0170","doi-asserted-by":"crossref","unstructured":"J. Li et al., \u201cCell-membrane-coated nanoparticles for targeted drug delivery to the brain for the treatment of neurological diseases,\u201d Pharm. 2023, Vol. 15, Page 621, vol. 15, no. 2, p. 621, Feb. 2023, doi:https:\/\/doi.org\/10.3390\/PHARMACEUTICS15020621.","DOI":"10.3390\/pharmaceutics15020621"},{"key":"10.1016\/j.bioadv.2026.214822_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1083645","article-title":"The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma","volume":"9","author":"Allami","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioadv.2026.214822_bb0180","doi-asserted-by":"crossref","unstructured":"T. Tashima, \u201cMesenchymal stem cell (MSC)-based drug delivery into the brain across the blood\u2013brain barrier,\u201d Pharmaceutics 2024, Vol. 16, Page 289, vol. 16, no. 2, p. 289, Feb. 2024, doi:https:\/\/doi.org\/10.3390\/PHARMACEUTICS16020289.","DOI":"10.3390\/pharmaceutics16020289"},{"key":"10.1016\/j.bioadv.2026.214822_bb0185","doi-asserted-by":"crossref","unstructured":"J. H. Sampson, M. D. Gunn, P. E. Fecci, and D. M. Ashley, \u201cBrain immunology and immunotherapy in brain tumours,\u201d Nat. Rev. Cancer 2019 201, vol. 20, no. 1, pp. 12\u201325, Dec. 2019, doi:https:\/\/doi.org\/10.1038\/s41568-019-0224-7.","DOI":"10.1038\/s41568-019-0224-7"},{"key":"10.1016\/j.bioadv.2026.214822_bb0190","doi-asserted-by":"crossref","unstructured":"J. Bi, S. Chowdhry, S. Wu, W. Zhang, K. Masui, and P. S. Mischel, \u201cAltered cellular metabolism in gliomas \u2014 an emerging landscape of actionable co-dependency targets,\u201d Nat. Rev. Cancer 2019 201, vol. 20, no. 1, pp. 57\u201370, Dec. 2019, doi:https:\/\/doi.org\/10.1038\/s41568-019-0226-5.","DOI":"10.1038\/s41568-019-0226-5"},{"issue":"18","key":"10.1016\/j.bioadv.2026.214822_bb0195","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1002\/adma.201506086","article-title":"Cancer cell membrane-coated Upconversion Nanoprobes for highly specific tumor imaging","volume":"28","author":"Rao","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.214822_bb0200","doi-asserted-by":"crossref","unstructured":"J. C. Harris, M. A. Scully, and E. S. Day, \u201cCancer cell membrane-coated nanoparticles for cancer management,\u201d Cancers 2019, Vol. 11, Page 1836, vol. 11, no. 12, p. 1836, Nov. 2019, doi:https:\/\/doi.org\/10.3390\/CANCERS11121836.","DOI":"10.3390\/cancers11121836"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214822_bb0205","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","article-title":"Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes","volume":"16","author":"Zhu","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214822_bb0210","doi-asserted-by":"crossref","first-page":"1599340","DOI":"10.3389\/fmed.2025.1599340","article-title":"Artificial intelligence based advancements in nanomedicine for brain disorder management: an updated narrative review","volume":"12","author":"Dipankar","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.bioadv.2026.214822_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113305","article-title":"Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: at a glance","volume":"153","author":"Rahman","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00210-021-02196-x","article-title":"Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review","volume":"395","author":"Moradi","year":"2022","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0225","doi-asserted-by":"crossref","unstructured":"A. Maria de Souza Antunes, M. Simone de Menezes Alencar, C. Henrique da Silva, J. Nunes, and F. Maria Lins Mendes, \u201cTrends in nanotechnology patents applied to the health sector,\u201d Recent Pat. Nanotechnol., vol. 6, no. 1, pp. 29\u201343, Nov. 2011, doi:https:\/\/doi.org\/10.2174\/187221012798109309.","DOI":"10.2174\/187221012798109309"},{"key":"10.1016\/j.bioadv.2026.214822_bb0230","doi-asserted-by":"crossref","unstructured":"S. M. Mousavi et al., \u201cRecent progress in chemical composition, production, and pharmaceutical effects of Kombucha beverage: a complementary and alternative medicine,\u201d Evid. Based Complement. Alternat. Med., vol. 2020, no. 1, p. 4397543, Jan. 2020, doi:https:\/\/doi.org\/10.1155\/2020\/4397543.","DOI":"10.1155\/2020\/4397543"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0235","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.nanolett.9b03817","article-title":"Cancer-cell-membrane-coated nanoparticles with a yolk-shell structure augment cancer chemotherapy","volume":"20","author":"Nie","year":"2020","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb0240","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214822_bb0245","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.12.066","article-title":"Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases","volume":"378","author":"Zhao","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0250","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1186\/s12885-025-14433-0","article-title":"Biomimetic cancer cell membrane engineered lipid nanoparticles for enhanced chemotherapy of homologous malignant tumor","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioadv.2026.214822_bb0255","doi-asserted-by":"crossref","unstructured":"\u201cA current view on inflammation,\u201d Nat. Immunol. 2017 188, vol. 18, no. 8, pp. 825\u2013825, Jul. 2017, doi:https:\/\/doi.org\/10.1038\/ni.3798.","DOI":"10.1038\/ni.3798"},{"key":"10.1016\/j.bioadv.2026.214822_bb0260","doi-asserted-by":"crossref","first-page":"630352","DOI":"10.3389\/fbioe.2021.630352","article-title":"Update on nanoparticle-based drug delivery system for anti-inflammatory treatment","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0265","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2020.06.030","article-title":"Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites","volume":"167","author":"Cao","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6917","key":"10.1016\/j.bioadv.2026.214822_bb0270","first-page":"860","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nat. 2002 4206917"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0275","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","article-title":"Cancer related inflammation: the macrophage connection","volume":"267","author":"Sica","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2026.214822_bb0280","doi-asserted-by":"crossref","unstructured":"L. Liu, H. He, and J. Liu, \u201cAdvances on non-genetic cell membrane engineering for biomedical applications,\u201d Polymers 2019, Vol. 11, Page 2017, vol. 11, no. 12, p. 2017, Dec. 2019, doi:https:\/\/doi.org\/10.3390\/POLYM11122017.","DOI":"10.3390\/polym11122017"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acsnano.7b07720","article-title":"Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis","volume":"12","author":"Wei","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214822_bb0290","doi-asserted-by":"crossref","unstructured":"S. M. Mousavi et al., \u201cGreen synthesis of supermagnetic Fe3O4\u2013MgO nanoparticles via nutmeg essential oil toward superior anti-bacterial and anti-fungal performance,\u201d J. Drug Delivery Sci. Technol., vol. 54, p. 101352, Dec. 2019, doi:https:\/\/doi.org\/10.1016\/J.JDDST.2019.101352.","DOI":"10.1016\/j.jddst.2019.101352"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-025-02321-w","article-title":"Neutrophil membrane-coated circular RNA nanoparticles for targeted immunotherapy in HER2-positive breast cancer brain metastasis","volume":"23","author":"Liu","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214822_bb0300","first-page":"655","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov. 2014 139"},{"issue":"7446","key":"10.1016\/j.bioadv.2026.214822_bb0305","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2026.214822_bb0310","doi-asserted-by":"crossref","unstructured":"V. Vijayan, S. Uthaman, and I. K. Park, \u201cCell membrane-camouflaged nanoparticles: a promising biomimetic strategy for cancer theragnostics,\u201d Polymers 2018, Vol. 10, Page 983, vol. 10, no. 9, p. 983, Sep. 2018, doi:https:\/\/doi.org\/10.3390\/POLYM10090983.","DOI":"10.3390\/polym10090983"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0315","first-page":"529","article-title":"Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioadv.2026.214822_bb0320","doi-asserted-by":"crossref","unstructured":"S. Liebner, R. M. Dijkhuizen, Y. Reiss, K. H. Plate, D. Agalliu, and G. Constantin, \u201cFunctional morphology of the blood\u2013brain barrier in health and disease,\u201d Acta Neuropathol. 2018 1353, vol. 135, no. 3, pp. 311\u2013336, Feb. 2018, doi:https:\/\/doi.org\/10.1007\/S00401-018-1815-1.","DOI":"10.1007\/s00401-018-1815-1"},{"key":"10.1016\/j.bioadv.2026.214822_bb0325","doi-asserted-by":"crossref","unstructured":"U. H. Langen, S. Ayloo, and C. Gu, \u201cDevelopment and cell biology of the blood-brain barrier,\u201d Annu. Rev. Cell Dev. Biol., vol. 35, no. Volume 35, 2019, pp. 591\u2013613, Oct. 2019, doi:https:\/\/doi.org\/10.1146\/ANNUREV-CELLBIO-100617-062608\/CITE\/REFWORKS.","DOI":"10.1146\/annurev-cellbio-100617-062608"},{"issue":"9423","key":"10.1016\/j.bioadv.2026.214822_bb0330","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson\u2019s disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bioadv.2026.214822_bb0335","doi-asserted-by":"crossref","unstructured":"S. Y. Chuang, C. H. Lin, T. H. Huang, and J. Y. Fang, \u201cLipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis,\u201d Nanomaterials 2018, Vol. 8, Page 42, vol. 8, no. 1, p. 42, Jan. 2018, doi:https:\/\/doi.org\/10.3390\/NANO8010042.","DOI":"10.3390\/nano8010042"},{"key":"10.1016\/j.bioadv.2026.214822_bb0340","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","article-title":"M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization","volume":"341","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0345","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0350","doi-asserted-by":"crossref","unstructured":"R. Li et al., \u201cMacrophage membrane-coated nanoparticles sensitize glioblastoma to radiation by suppressing proneural\u2013mesenchymal transformation in glioma stem cells,\u201d Adv. Funct. Mater., vol. 33, no. 37, p. 2213292, Sep. 2023, doi:https:\/\/doi.org\/10.1002\/ADFM.202213292.","DOI":"10.1002\/adfm.202213292"},{"key":"10.1016\/j.bioadv.2026.214822_bb0355","doi-asserted-by":"crossref","unstructured":"S. Yuan et al., \u201cRecent advances of engineering cell membranes for nanomedicine delivery across the blood\u2013brain barrier,\u201d J. Nanobiotechnol., vol. 23, no. 1, pp. 1\u201322, Dec. 2025, doi:https:\/\/doi.org\/10.1186\/S12951-025-03572-Y\/FIGURES\/9.","DOI":"10.1186\/s12951-025-03572-y"},{"key":"10.1016\/j.bioadv.2026.214822_bb0360","doi-asserted-by":"crossref","unstructured":"B. Aslam et al., \u201cAntibiotic resistance: a rundown of a global crisis,\u201d Infect. Drug Resist., vol. 11, pp. 1645\u20131658, 2018, doi:https:\/\/doi.org\/10.2147\/IDR.S173867.","DOI":"10.2147\/IDR.S173867"},{"issue":"10","key":"10.1016\/j.bioadv.2026.214822_bb0365","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioadv.2026.214822_bb0370","doi-asserted-by":"crossref","unstructured":"Y. Fang et al., \u201cArtificial assembled macrophage co-deliver black phosphorus quantum dot and CDK4\/6 inhibitor for colorectal cancer triple-therapy,\u201d ACS Appl. Mater. Interfaces, vol. 14, no. 18, pp. 20628\u201320640, May 2022, doi:https:\/\/doi.org\/10.1021\/ACSAMI.2C01305\/SUPPL_FILE\/AM2C01305_SI_001.PDF.","DOI":"10.1021\/acsami.2c01305"},{"issue":"36","key":"10.1016\/j.bioadv.2026.214822_bb0375","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1021\/acs.langmuir.5b02005","article-title":"Antibacterial activity and biosensing of PVA-lysozyme microbubbles formed by pressurized gyration","volume":"31","author":"Mahalingam","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.bioadv.2026.214822_bb0380","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2017.09.015","article-title":"Nanoparticle-based local antimicrobial drug delivery","volume":"127","author":"Gao","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0385","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/nl504798g","article-title":"Modulating antibacterial immunity via bacterial membrane-coated nanoparticles","volume":"15","author":"Gao","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214822_bb0390","doi-asserted-by":"crossref","unstructured":"Z. Bai et al., \u201cHarnessing bacterial membrane components for tumor vaccines: strategies and perspectives,\u201d Adv. Healthc. Mater., vol. 13, no. 26, p. 2401615, Oct. 2024, doi:https:\/\/doi.org\/10.1002\/ADHM.202401615;REQUESTEDJOURNAL:JOURNAL:21922659.","DOI":"10.1002\/adhm.202401615"},{"key":"10.1016\/j.bioadv.2026.214822_bb0395","doi-asserted-by":"crossref","unstructured":"X. Ai et al., \u201cRecent advances of membrane-cloaked nanoplatforms for biomedical applications,\u201d Bioconjug. Chem., vol. 29, no. 4, pp. 838\u2013851, Apr. 2018, doi:https:\/\/doi.org\/10.1021\/ACS.BIOCONJCHEM.8B00103\/ASSET\/IMAGES\/MEDIUM\/BC-2018-00103X_0008.GIF.","DOI":"10.1021\/acs.bioconjchem.8b00103"},{"key":"10.1016\/j.bioadv.2026.214822_bb0400","doi-asserted-by":"crossref","unstructured":"Z. Peng et al., \u201cAgomir-122-loaded nanoparticles coated with cell membrane of activated fibroblasts to treat frozen shoulder based on homologous targeting,\u201d J. Nanobiotechnology 2024 221, vol. 22, no. 1, pp. 1\u201313, Apr. 2024, doi:https:\/\/doi.org\/10.1186\/S12951-024-02403-W, J. Nanobiotechnol.","DOI":"10.1186\/s12951-024-02403-w"},{"issue":"7193","key":"10.1016\/j.bioadv.2026.214822_bb0405","first-page":"314","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nat. 2008 4537193"},{"key":"10.1016\/j.bioadv.2026.214822_bb0410","doi-asserted-by":"crossref","unstructured":"T. A. Wynn and T. R. Ramalingam, \u201cMechanisms of fibrosis: therapeutic translation for fibrotic disease,\u201d Nat. Med. 2012 187, vol. 18, no. 7, pp. 1028\u20131040, Jul. 2012, doi:https:\/\/doi.org\/10.1038\/nm.2807.","DOI":"10.1038\/nm.2807"},{"key":"10.1016\/j.bioadv.2026.214822_bb0415","doi-asserted-by":"crossref","unstructured":"Y. Liu et al., \u201cRegulatory fibroblast-like synoviocytes cell membrane coated nanoparticles: a novel targeted therapy for rheumatoid arthritis,\u201d Adv. Sci., vol. 10, no. 4, p. 2204998, Feb. 2023, doi:https:\/\/doi.org\/10.1002\/ADVS.202204998;WGROUP:STRING:PUBLICATION.","DOI":"10.1002\/advs.202204998"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"27","key":"10.1016\/j.bioadv.2026.214822_bb0425","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioadv.2026.214822_bb0430","doi-asserted-by":"crossref","unstructured":"M. Gao et al., \u201cErythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy,\u201d Adv. Mater., vol. 29, no. 35, p. 1701429, Sep. 2017, doi:https:\/\/doi.org\/10.1002\/ADMA.201701429.","DOI":"10.1002\/adma.201701429"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214822_bb0435","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1039\/C6BM00072J","article-title":"Erythrocytes in nanomedicine: an optimal blend of natural and synthetic materials","volume":"4","author":"Zhang","year":"2016","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214822_bb0440","first-page":"447","article-title":"Global and regional cause-of-death patterns in 1990","volume":"72","author":"Murray","year":"1994","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.bioadv.2026.214822_bb0445","doi-asserted-by":"crossref","unstructured":"T. Finkel and N. J. Holbrook, \u201cOxidants, oxidative stress and the biology of ageing,\u201d Nat. 2000 4086809, vol. 408, no. 6809, pp. 239\u2013247, Nov. 2000, doi:https:\/\/doi.org\/10.1038\/35041687, Nature.","DOI":"10.1038\/35041687"},{"key":"10.1016\/j.bioadv.2026.214822_bb0450","series-title":"Handb. Exp. Pharmacol.","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-642-00477-3_2","article-title":"Nanoparticles Technologies for Cancer Therapy","volume":"197","author":"Frank","year":"2010"},{"key":"10.1016\/j.bioadv.2026.214822_bb0455","doi-asserted-by":"crossref","unstructured":"D. Dehaini et al., \u201cErythrocyte\u2013platelet hybrid membrane coating for enhanced nanoparticle functionalization,\u201d Adv. Mater., vol. 29, no. 16, p. 1606209, Apr. 2017, doi:https:\/\/doi.org\/10.1002\/ADMA.201606209.","DOI":"10.1002\/adma.201770107"},{"key":"10.1016\/j.bioadv.2026.214822_bb0460","doi-asserted-by":"crossref","unstructured":"X. Wei et al., \u201cIn situ capture of bacterial toxins for antivirulence vaccination,\u201d Adv. Mater., vol. 29, no. 33, p. 1701644, Sep. 2017, doi:https:\/\/doi.org\/10.1002\/ADMA.201701644.","DOI":"10.1002\/adma.201701644"},{"key":"10.1016\/j.bioadv.2026.214822_bb0465","doi-asserted-by":"crossref","unstructured":"R. R. Lin et al., \u201cHybrid membrane-coated nanoparticles for precise targeting and synergistic therapy in Alzheimer's disease,\u201d Adv. Sci., vol. 11, no. 24, p. 2306675, Jun. 2024, doi:https:\/\/doi.org\/10.1002\/ADVS.202306675.","DOI":"10.1002\/advs.202306675"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0470","article-title":"Neural stem cell-derived extracellular vesicles mitigate Alzheimer\u2019s disease-like phenotypes in a preclinical mouse model","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040571","article-title":"Insights into exosome transport through the blood-brain barrier and the potential therapeutical applications in brain diseases","volume":"16","author":"Abdelsalam","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214822_bb0480","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14752","article-title":"Exosomes as a therapeutic tool to promote neurorestoration and cognitive function in neurological conditions: achieve two ends with a single effort","volume":"30","author":"Fallahi","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioadv.2026.214822_bb0485","doi-asserted-by":"crossref","unstructured":"M. C. Chiang, Y. P. Yang, C. J. B. Nicol, T. Chiang, and C. Yen, \u201cResveratrol-enhanced human neural stem cell-derived exosomes mitigate MPP+-induced neurotoxicity through activation of AMPK and Nrf2 pathways and inhibition of the NLRP3 inflammasome in SH-SY5Y cells,\u201d Life (Basel, Switzerland), vol. 15, no. 2, Feb. 2025, doi:https:\/\/doi.org\/10.3390\/LIFE15020294.","DOI":"10.3390\/life15020294"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102373","article-title":"Delivering therapeutic RNA into the brain using extracellular vesicles","volume":"35","author":"Shirmast","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb0495","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/14712598.2012.661710","article-title":"Nanoparticles disguised as red blood cells to evade the immune system","volume":"12","author":"Fang","year":"2012","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-023-00287-1","article-title":"Stem cell-based drug delivery strategy for skin regeneration and wound healing: potential clinical applications","volume":"43","author":"Zhang","year":"2023","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.bioadv.2026.214822_bb0505","doi-asserted-by":"crossref","unstructured":"M. Abudurexiti et al., \u201cBio-inspired nanocarriers derived from stem cells and their extracellular vesicles for targeted drug delivery,\u201d Pharmaceutics, vol. 15, no. 7, p. 2011, Jul. 2023, doi:https:\/\/doi.org\/10.3390\/PHARMACEUTICS15072011.","DOI":"10.3390\/pharmaceutics15072011"},{"issue":"12","key":"10.1016\/j.bioadv.2026.214822_bb0510","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1097\/JS9.0000000000002082","article-title":"Current advancements in nanotechnology for stem cells","volume":"110","author":"Thamarai","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.bioadv.2026.214822_bb0515","doi-asserted-by":"crossref","unstructured":"T. Barreto da Silva, E. A. Dias, L. M. da F. Cardoso, J. F. G. Gama, L. A. Alves, and A. Henriques-Pons, \u201cMagnetic nanostructures and stem cells for regenerative medicine, application in liver diseases,\u201d Int. J. Mol. Sci. 2023, Vol. 24, Page 9293, vol. 24, no. 11, p. 9293, May 2023, doi:https:\/\/doi.org\/10.3390\/IJMS24119293.","DOI":"10.3390\/ijms24119293"},{"issue":"3","key":"10.1016\/j.bioadv.2026.214822_bb0520","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2026.214822_bb0525","doi-asserted-by":"crossref","unstructured":"Y. Liu, J. Luo, X. Chen, W. Liu, and T. Chen, \u201cCell membrane coating technology: a promising strategy for biomedical applications,\u201d Nano-Micro Lett. 2019 111, vol. 11, no. 1, pp. 1\u201346, Nov. 2019, doi:https:\/\/doi.org\/10.1007\/S40820-019-0330-9, Nano-Micro Lett.","DOI":"10.1007\/s40820-019-0330-9"},{"issue":"11","key":"10.1016\/j.bioadv.2026.214822_bb0530","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1021\/acs.nanolett.9b02841","article-title":"Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214822_bb0535","doi-asserted-by":"crossref","unstructured":"W. Song et al., \u201cCell membrane-camouflaged inorganic nanoparticles for cancer therapy,\u201d J. Nanobiotechnology 2022 201, vol. 20, no. 1, pp. 1\u201329, Jun. 2022, doi:https:\/\/doi.org\/10.1186\/S12951-022-01475-W, J. Nanobiotechnol.","DOI":"10.1186\/s12951-022-01475-w"},{"key":"10.1016\/j.bioadv.2026.214822_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.01.036","article-title":"Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy","volume":"105","author":"Xu","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2026.214822_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2026.214822_bb0550","doi-asserted-by":"crossref","unstructured":"L. Rao et al., \u201cMicrofluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided Cancer therapy,\u201d ACS Nano, vol. 11, no. 4, pp. 3496\u20133505, Apr. 2017, doi:https:\/\/doi.org\/10.1021\/ACSNANO.7B00133\/SUPPL_FILE\/NN7B00133_SI_001.PDF.","DOI":"10.1021\/acsnano.7b00133"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214822_bb0555","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/acsbiomaterials.8b00197","article-title":"Red blood cell-shaped microparticles with a red blood cell membrane demonstrate prolonged circulation time in blood","volume":"4","author":"Hayashi","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioadv.2026.214822_bb0560","doi-asserted-by":"crossref","unstructured":"J. Tang et al., \u201cTherapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome,\u201d Nat. Commun. 2017 81, vol. 8, no. 1, pp. 1\u20139, Jan. 2017, doi:https:\/\/doi.org\/10.1038\/ncomms13724.","DOI":"10.1038\/ncomms13724"},{"key":"10.1016\/j.bioadv.2026.214822_bb0565","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biomaterials.2018.08.018","article-title":"Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia","volume":"185","author":"Bose","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214822_bb0570","doi-asserted-by":"crossref","unstructured":"R. Arrigo, R. Teresi, C. Gambarotti, F. Parisi, G. Lazzara, and N. T. Dintcheva, \u201cSonication-induced modification of carbon nanotubes: effect on the rheological and thermo-oxidative behaviour of polymer-based nanocomposites,\u201d Materials 2018, Vol. 11, Page 383, vol. 11, no. 3, p. 383, Mar. 2018, doi:https:\/\/doi.org\/10.3390\/MA11030383.","DOI":"10.3390\/ma11030383"},{"key":"10.1016\/j.bioadv.2026.214822_bb0575","doi-asserted-by":"crossref","unstructured":"H. Rennhofer and B. Zanghellini, \u201cDispersion state and damage of carbon nanotubes and carbon nanofibers by ultrasonic dispersion: a review,\u201d Nanomaterials 2021, Vol. 11, Page 1469, vol. 11, no. 6, p. 1469, Jun. 2021, doi:https:\/\/doi.org\/10.3390\/NANO11061469.","DOI":"10.3390\/nano11061469"},{"issue":"37","key":"10.1016\/j.bioadv.2026.214822_bb0580","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1412420111","article-title":"Clearance of pathological antibodies using biomimetic nanoparticles","volume":"111","author":"Copp","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2\u20133","key":"10.1016\/j.bioadv.2026.214822_bb0585","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0925-4005(01)00859-0","article-title":"Electroporation microchips for continuous gene transfection","volume":"79","author":"Lin","year":"2001","journal-title":"Sens. Actuators B"},{"issue":"11","key":"10.1016\/j.bioadv.2026.214822_bb0590","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1007\/s11431-008-0109-6","article-title":"In situ preparation of nanoparticles\/polymer composites","volume":"51","author":"Sun","year":"2008","journal-title":"Sci. China Ser. E Technol. Sci."},{"issue":"10","key":"10.1016\/j.bioadv.2026.214822_bb0595","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1007\/s12274-018-2080-2","article-title":"In situ polymerization on biomacromolecules for nanomedicines","volume":"11","author":"Jia","year":"2018","journal-title":"Nano Res."},{"issue":"15","key":"10.1016\/j.bioadv.2026.214822_bb0600","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1039\/C7TB00038C","article-title":"Electroporation for nanomedicine: a review","volume":"5","author":"Kim","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"14","key":"10.1016\/j.bioadv.2026.214822_bb0605","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0610","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03572-y","article-title":"Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier","volume":"23","author":"Yuan","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0615","doi-asserted-by":"crossref","unstructured":"C. Iadecola and J. Anrather, \u201cThe immunology of stroke: from mechanisms to translation,\u201d Nat. Med. 2011 177, vol. 17, no. 7, pp. 796\u2013808, Jul. 2011, doi:https:\/\/doi.org\/10.1038\/nm.2399.","DOI":"10.1038\/nm.2399"},{"issue":"10244","key":"10.1016\/j.bioadv.2026.214822_bb0620","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(20)31179-X","article-title":"Stroke","volume":"396","author":"Campbell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2026.214822_bb0625","doi-asserted-by":"crossref","unstructured":"B. C. V. Campbell et al., \u201cIschaemic stroke,\u201d Nat. Rev. Dis. Primers, vol. 5, no. 1, p. 70, Oct. 2019, doi:https:\/\/doi.org\/10.1038\/s41572-019-0118-8.","DOI":"10.1038\/s41572-019-0126-8"},{"key":"10.1016\/j.bioadv.2026.214822_bb0630","doi-asserted-by":"crossref","unstructured":"M. Fiorelli et al., \u201cHemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European cooperative acute stroke study I (ECASS I) cohort,\u201d Stroke, vol. 30, no. 11, pp. 2280\u20132284, 1999, doi:https:\/\/doi.org\/10.1161\/01.STR.30.11.2280\/ASSET\/DD7C2C68-00FB-4654-B1E3-8F77A344C891\/ASSETS\/GRAPHIC\/HS1091474003.JPEG.","DOI":"10.1161\/01.STR.30.11.2280"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214822_bb0635","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/10717544.2011.589084","article-title":"Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury","volume":"18","author":"Xu","year":"2011","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214822_bb0640","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jnc.12507","article-title":"Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain","volume":"128","author":"Fang","year":"2014","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.bioadv.2026.214822_bb0645","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1007\/s12035-021-02376-z","article-title":"Oxiracetam mediates neuroprotection through the regulation of microglia under hypoxia-ischemia neonatal brain injury in mice","volume":"58","author":"Wang","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0650","doi-asserted-by":"crossref","unstructured":"W. A. Banks, \u201cFrom blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery,\u201d Nat. Rev. Drug Discov. 2016 154, vol. 15, no. 4, pp. 275\u2013292, Jan. 2016, doi:https:\/\/doi.org\/10.1038\/nrd.2015.21, Nat. Rev. Drug Discov.","DOI":"10.1038\/nrd.2015.21"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0655","first-page":"1272","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214822_bb0660","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioadv.2026.214822_bb0665","doi-asserted-by":"crossref","unstructured":"M. Spite et al., \u201cResolvin D2 is a potent regulator of leukocytes and controls microbial sepsis,\u201d Nat. 2009 4617268, vol. 461, no. 7268, pp. 1287\u20131291, Oct. 2009, doi:https:\/\/doi.org\/10.1038\/nature08541, Nature.","DOI":"10.1038\/nature08541"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0670","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","article-title":"Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery","volume":"15","author":"Feng","year":"2021","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214822_bb0675","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.002","article-title":"The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome","volume":"23","author":"Molnar","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0680","first-page":"100","article-title":"The relation between GABA and L-arginine levels with some stroke risk factors in acute ischemic stroke patients","volume":"5","author":"Hosinian","year":"2016","journal-title":"Int. J. Mol. Cell. Med."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0685","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/2211738510666220210105113","article-title":"Theranostic applications of stimulus-responsive systems based on Fe2O3","volume":"10","author":"Pourmadadi","year":"2022","journal-title":"Pharm. Nanotechnol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0690","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","article-title":"Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214822_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105924","article-title":"RGD-decorated nanoparticles: therapeutic potential beyond cancer","volume":"98","author":"Hosseinikhah","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0700","doi-asserted-by":"crossref","unstructured":"C. Tapeinos et al., \u201cAdvanced functional materials and cell-based therapies for the treatment of ischemic stroke and postischemic stroke effects,\u201d Adv. Funct. Mater., vol. 30, no. 1, p. 1906283, Jan. 2020, doi:https:\/\/doi.org\/10.1002\/ADFM.201906283.","DOI":"10.1002\/adfm.201906283"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-023-02253-y","article-title":"Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0710","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/138945012799201603","article-title":"Roles of chemokine CXCL12 and its receptors in ischemic stroke","volume":"13","author":"Wang","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioadv.2026.214822_bb0715","doi-asserted-by":"crossref","unstructured":"X. Q. Zhang et al., \u201cC-X-C chemokine receptor type 7 antibody enhances neural plasticity after ischemic stroke,\u201d Neural Regen. Res., vol. 18, no. 9, pp. 1976\u20131982, Sep. 2023, doi:https:\/\/doi.org\/10.4103\/1673-5374.363835.","DOI":"10.4103\/1673-5374.363835"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0720","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbrc.2015.06.135","article-title":"Stromal cell-derived factor-1 alpha alleviates hypoxic-ischemic brain damage in mice","volume":"464","author":"Yu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214822_bb0725","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1468-1331.2011.03527.x","article-title":"Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?","volume":"19","author":"Wurster","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0730","doi-asserted-by":"crossref","unstructured":"J. Ma et al., \u201cTargeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells,\u201d Small, vol. 15, no. 35, p. 1902011, Aug. 2019, doi:https:\/\/doi.org\/10.1002\/SMLL.201902011.","DOI":"10.1002\/smll.201902011"},{"issue":"16","key":"10.1016\/j.bioadv.2026.214822_bb0735","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.7150\/thno.60785","article-title":"Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics"},{"issue":"17","key":"10.1016\/j.bioadv.2026.214822_bb0740","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1021\/acs.nanolett.4c00650","article-title":"Sulfated polysaccharide-based Nanocarrier drives microenvironment-mediated cerebral neurovascular remodeling for ischemic stroke treatment","volume":"24","author":"Cao","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214822_bb0745","doi-asserted-by":"crossref","unstructured":"J. Song et al., \u201cNeutrophil hitchhiking biomimetic nanozymes prime neuroprotective effects of ischemic stroke in a tailored \u2018burning the bridges\u2019 manner,\u201d Adv. Funct. Mater., vol. 34, no. 32, p. 2315275, Aug. 2024, doi:https:\/\/doi.org\/10.1002\/ADFM.202315275;PAGEGROUP:STRING:PUBLICATION.","DOI":"10.1002\/adfm.202315275"},{"key":"10.1016\/j.bioadv.2026.214822_bb0750","doi-asserted-by":"crossref","unstructured":"L. Tang et al., \u201cBlood\u2013brain barrier-penetrating and lesion-targeting nanoplatforms inspired by the pathophysiological features for synergistic ischemic stroke therapy,\u201d Adv. Mater., vol. 36, no. 21, p. 2312897, May 2024, doi:https:\/\/doi.org\/10.1002\/ADMA.202312897;PAGE:STRING:ARTICLE\/CHAPTER.","DOI":"10.1002\/adma.202312897"},{"key":"10.1016\/j.bioadv.2026.214822_bb0755","doi-asserted-by":"crossref","unstructured":"Y. Zhao et al., \u201cNeutrophil membrane-camouflaged polyprodrug nanomedicine for inflammation suppression in ischemic stroke therapy,\u201d Adv. Mater., vol. 36, no. 21, p. 2311803, May 2024, doi:https:\/\/doi.org\/10.1002\/ADMA.202311803;ISSUE:ISSUE:DOI.","DOI":"10.1002\/adma.202311803"},{"key":"10.1016\/j.bioadv.2026.214822_bb0760","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jconrel.2024.11.033","article-title":"Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke","volume":"378","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.214822_bb0765","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.actbio.2025.02.061","article-title":"Neutrophil-like cell membrane-coated metal-organic frameworks for siRNA delivery targeting NOX4 to alleviate oxidative stress in acute ischemic injury","volume":"196","author":"Wang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2026.214822_bb0770","series-title":"Malig. Brain Tumors State-of-the-Art Treat","first-page":"265","article-title":"Glioblastoma","author":"Wirsching","year":"2017"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0775","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1553350615604053","article-title":"Indocyanine green","volume":"23","author":"Reinhart","year":"2016","journal-title":"Surg. Innov."},{"issue":"14","key":"10.1016\/j.bioadv.2026.214822_bb0780","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909369","article-title":"Camouflaging nanoparticles with brain metastatic tumor cell membranes: a new strategy to traverse blood\u2013brain barrier for imaging and therapy of brain tumors","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioadv.2026.214822_bb0785","doi-asserted-by":"crossref","unstructured":"A. J. A. Terzis et al., \u201cProliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro,\u201d Br. J. Cancer 1997 7512, vol. 75, no. 12, pp. 1744\u20131752, 1997, doi:https:\/\/doi.org\/10.1038\/bjc.1997.298.","DOI":"10.1038\/bjc.1997.298"},{"issue":"12","key":"10.1016\/j.bioadv.2026.214822_bb0790","first-page":"4402","article-title":"Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma","volume":"6","author":"Fan","year":"2021","journal-title":"Bioact. Mater."},{"issue":"16","key":"10.1016\/j.bioadv.2026.214822_bb0795","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","author":"Yin","year":"2022","journal-title":"Nano Lett."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2026.214822_bb0800","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.03.028","article-title":"RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy","volume":"543","author":"Hua","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214822_bb0805","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/187152007781668706","article-title":"Tumor targeting with RGD peptide ligands-Design of new Molecular Conjugates for imaging and therapy of cancers","volume":"7","author":"Garanger","year":"2012","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214822_bb0810","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/acsnano.9b00661","article-title":"Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma","volume":"13","author":"Chai","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.214822_bb0815","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.phytochem.2014.04.020","article-title":"Lathyrane-type diterpenoids from the seeds of Euphorbia lathyris","volume":"104","author":"Lu","year":"2014","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioadv.2026.214822_bb0820","doi-asserted-by":"crossref","unstructured":"J. Y. Zhang et al., \u201cApoptosis sensitization by Euphorbia factor L1 in ABCB1-mediated multidrug resistant K562\/ADR cells,\u201d Molecules 2013, Vol. 18, Pages 12793\u201312808, vol. 18, no. 10, pp. 12793\u201312808, Oct. 2013, doi:https:\/\/doi.org\/10.3390\/MOLECULES181012793.","DOI":"10.3390\/molecules181012793"},{"key":"10.1016\/j.bioadv.2026.214822_bb0825","doi-asserted-by":"crossref","unstructured":"K. Seidi et al., \u201cNGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth,\u201d Oncogene 2018 3729, vol. 37, no. 29, pp. 3967\u20133980, Apr. 2018, doi:https:\/\/doi.org\/10.1038\/s41388-018-0213-4.","DOI":"10.1038\/s41388-018-0213-4"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214822_bb0830","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1039\/C4NR07027E","article-title":"Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane","volume":"7","author":"Fu","year":"2015","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.bioadv.2026.214822_bb0835","doi-asserted-by":"crossref","first-page":"20377","DOI":"10.1021\/acsnano.1c08689","article-title":"Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy\/chemodynamic therapy of orthotopic glioma","volume":"15","author":"Xiao","year":"2021","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214822_bb0840","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/ph15091059","article-title":"Hybrid membrane-derived nanoparticles for isoliquiritin enhanced glioma therapy","volume":"15","author":"Shi","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.bioadv.2026.214822_bb0845","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2174\/1389201022666210719164538","article-title":"Erythrocyte-cancer hybrid membrane-camouflaged mesoporous silica nanoparticles loaded with Gboxin for glioma-targeting therapy","volume":"23","author":"Jiao","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bioadv.2026.214822_bb0850","doi-asserted-by":"crossref","unstructured":"L. Wu et al., \u201cPlatelet-tumor cell hybrid membrane-camouflaged nanoparticles for enhancing therapy efficacy in glioma,\u201d Int. J. Nanomedicine, vol. 16, pp. 8433\u20138446, 2021, doi:https:\/\/doi.org\/10.2147\/IJN.S333279.","DOI":"10.2147\/IJN.S333279"},{"issue":"24","key":"10.1016\/j.bioadv.2026.214822_bb0855","doi-asserted-by":"crossref","first-page":"35288","DOI":"10.1021\/acsami.5c07306","article-title":"Breaking barriers in glioblastoma targeting through advanced nanoparticle cell membrane coating","volume":"17","author":"Jim\u00e9nez-Boland","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0860","first-page":"226","article-title":"Pathophysiology and management of alzheimer \u2019 s disease\u202f: an overview","volume":"7","author":"Article","year":"2018","journal-title":"J. Anal. Pharm. Res."},{"key":"10.1016\/j.bioadv.2026.214822_bb0865","doi-asserted-by":"crossref","unstructured":"P. Kamila et al., \u201cEffect of neuroinflammation on the progression of Alzheimer's disease and its significant ramifications for novel anti-inflammatory treatments,\u201d IBRO Neurosci. Reports, vol. 18, p. 771, Jun. 2025, doi:https:\/\/doi.org\/10.1016\/J.IBNEUR.2025.05.005, IBRO Neurosci. Rep.","DOI":"10.1016\/j.ibneur.2025.05.005"},{"key":"10.1016\/j.bioadv.2026.214822_bb0870","doi-asserted-by":"crossref","unstructured":"Z. Liu, A. Zhang, H. Sun, Y. Han, and X. Wang, \u201cRSC advances two decades of new drug discovery and development for Alzheimer \u2019 s disease \u2020,\u201d pp. 6046\u20136058, 2017, doi:https:\/\/doi.org\/10.1039\/c6ra26737h.","DOI":"10.1039\/C6RA26737H"},{"key":"10.1016\/j.bioadv.2026.214822_bb0875","doi-asserted-by":"crossref","unstructured":"M. Tolar et al., \u201cNeurotoxic soluble amyloid oligomers drive Alzheimer's pathogenesis and represent a clinically validated target for slowing disease progression,\u201d Int. J. Mol. Sci. 2021, Vol. 22, vol. 22, no. 12, Jun. 2021, doi:https:\/\/doi.org\/10.3390\/IJMS22126355.","DOI":"10.3390\/ijms22126355"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb0880","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4172\/pharmaceutical-sciences.1000397","article-title":"Pathogenesis of Alzheimer\u2019s disease: role of amyloid-beta and Hyperphosphorylated tau protein","volume":"80","author":"Sajjad","year":"2018","journal-title":"Indian J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.bioadv.2026.214822_bb0885","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other Tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0890","article-title":"A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"Sci. World J."},{"issue":"2015","key":"10.1016\/j.bioadv.2026.214822_bb0895","article-title":"Neuroinflammation in Alzheimer \u2019 s disease neuroinflammation in Alzheimer \u2019 s disease","volume":"6328","author":"Zhang","year":"2021"},{"issue":"11","key":"10.1016\/j.bioadv.2026.214822_bb0900","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-invasive drug delivery across the blood\u2013brain barrier: a prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.214822_bb0905","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood \u2013 brain barrier dysfunction as a cause and consequence of Alzheimer \u2019 s disease","author":"Erickson","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0910","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"10043","key":"10.1016\/j.bioadv.2026.214822_bb0915","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2026.214822_bb0920","first-page":"1","article-title":"Development of sustained release injectable phospholipid-based phase transition gel matrixed with Piracetam and cannabidiol loaded nanoemulsion for amelioration of Alzheimer\u2019s therapy","volume":"2025","author":"Shahrukh","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2026.214822_bb0925","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.653651","article-title":"Inflammation and insulin resistance as risk factors and potential therapeutic targets for Alzheimer\u2019s disease","volume":"15","author":"Vinuesa","year":"2021","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214822_bb0930","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"8","key":"10.1016\/j.bioadv.2026.214822_bb0935","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis: Progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"34","key":"10.1016\/j.bioadv.2026.214822_bb0940","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb0945","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JAD-2006-9206","article-title":"Mitochondrial dysfunction induced by disease relevant A\u03b2PP and tau protein mutations","volume":"9","author":"Keil","year":"2006","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.bioadv.2026.214822_bb0950","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2011.12.057","article-title":"Role of mitochondrial homeostasis and dynamics in Alzheimer\u2019s disease","volume":"51","author":"Selfridge","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0955","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/nyas.13431","article-title":"Resveratrol for Alzheimer\u2019s disease","volume":"1403","author":"Sawda","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb0960","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/10717544.2020.1745328","article-title":"Neuronal mitochondria-targeted therapy for Alzheimer\u2019s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems","volume":"27","author":"Han","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2026.214822_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175275","article-title":"Potential roles of genistein in polycystic ovary syndrome: a comprehensive systematic review","volume":"933","author":"Nasimi Doost Azgomi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.214822_bb0970","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer\u2019s disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214822_bb0975","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pharmthera.2013.04.013","article-title":"Microglia during development and aging","volume":"139","author":"Harry","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb0980","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14728222.2020.1738391","article-title":"Alzheimer\u2019s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation","volume":"24","author":"Anwar","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioadv.2026.214822_bb0985","doi-asserted-by":"crossref","unstructured":"D. Kaur, V. Sharma, and R. Deshmukh, \u201cActivation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease,\u201d Inflammopharmacology 2019 274, vol. 27, no. 4, pp. 663\u2013677, Mar. 2019, doi:https:\/\/doi.org\/10.1007\/S10787-019-00580-X.","DOI":"10.1007\/s10787-019-00580-x"},{"issue":"6286","key":"10.1016\/j.bioadv.2026.214822_bb0990","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science (80-. )."},{"issue":"33","key":"10.1016\/j.bioadv.2026.214822_bb0995","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective \u03b2-amyloid clearance pathways in aging Alzheimer\u2019s disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioadv.2026.214822_bb1000","series-title":"Chlorogenic Acid and Mental Diseases: From Chemistry to Medicine","author":"Fazel Nabavi","year":"2017"},{"key":"10.1016\/j.bioadv.2026.214822_bb1005","doi-asserted-by":"crossref","unstructured":"J. V. Pluvinage et al., \u201cCD22 blockade restores homeostatic microglial phagocytosis in ageing brains,\u201d Nat. 2019 5687751, vol. 568, no. 7751, pp. 187\u2013192, Apr. 2019, doi:https:\/\/doi.org\/10.1038\/s41586-019-1088-4, Nature.","DOI":"10.1038\/s41586-019-1088-4"},{"key":"10.1016\/j.bioadv.2026.214822_bb1010","doi-asserted-by":"crossref","unstructured":"Y. Su et al., \u201cStudy on the role of an erythrocyte membrane-coated nanotheranostic system in targeted immune regulation of Alzheimer's disease,\u201d Adv. Sci., vol. 10, no. 18, p. 2301361, Jun. 2023, doi:https:\/\/doi.org\/10.1002\/ADVS.202301361.","DOI":"10.1002\/advs.202301361"},{"issue":"33","key":"10.1016\/j.bioadv.2026.214822_bb1015","doi-asserted-by":"crossref","first-page":"47497","DOI":"10.1021\/acsami.5c09843","article-title":"Engineered stem cell membrane-coated Nanodrugs for targeted therapy of Alzheimer\u2019s disease","volume":"17","author":"Sha","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2026.214822_bb1020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-7091-6360-3_6","article-title":"Parkinson\u2019s disease \u2014 a multifactorial neurodegenerative disorder","volume":"56","author":"Riess","year":"1999","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.bioadv.2026.214822_bb1025","doi-asserted-by":"crossref","unstructured":"K. Wakabayashi, K. Tanji, S. Odagiri, Y. Miki, F. Mori, and H. Takahashi, \u201cThe Lewy body in Parkinson's disease and related neurodegenerative disorders,\u201d Mol. Neurobiol. 2012 472, vol. 47, no. 2, pp. 495\u2013508, May 2012, doi:https:\/\/doi.org\/10.1007\/S12035-012-8280-Y.","DOI":"10.1007\/s12035-012-8280-y"},{"key":"10.1016\/j.bioadv.2026.214822_bb1030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-323-95974-2.00021-9","article-title":"Pharmacology of Parkinson\u2019s disease","author":"Moini","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.bioadv.2026.214822_bb1035","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1212\/01.wnl.0000275524.15125.f4","article-title":"\u03b1-Synuclein and Parkinson disease susceptibility","volume":"69","author":"Winkler","year":"2007","journal-title":"Neurology"},{"issue":"5\u20136","key":"10.1016\/j.bioadv.2026.214822_bb1040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000488938","article-title":"Leucine-rich repeat kinase 2 in Parkinson\u2019s disease: updated from pathogenesis to potential therapeutic target","volume":"79","author":"Chen","year":"2018","journal-title":"Eur. Neurol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214822_bb1045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20319","article-title":"Analysis of the glucocerebrosidase gene in Parkinson\u2019s disease","volume":"20","author":"Sato","year":"2005","journal-title":"Mov. Disord."},{"issue":"10291","key":"10.1016\/j.bioadv.2026.214822_bb1050","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2026.214822_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104846","article-title":"The PI3K-AKT pathway: A plausible therapeutic target in Parkinson\u2019s disease","volume":"129","author":"Goyal","year":"2023","journal-title":"Exp. Mol. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2026.214822_bb1060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2005.12.042","article-title":"Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson\u2019s disease","volume":"398","author":"Chaturvedi","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214822_bb1065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","article-title":"Akt signal transduction dysfunction in Parkinson\u2019s disease","volume":"467","author":"Timmons","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"31","key":"10.1016\/j.bioadv.2026.214822_bb1070","doi-asserted-by":"crossref","first-page":"8314","DOI":"10.1523\/JNEUROSCI.1972-07.2007","article-title":"An endogenous serine\/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson\u2019s disease","volume":"27","author":"Chee","year":"2007","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb1075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acschemneuro.8b00356","article-title":"Balancing apoptosis and autophagy for Parkinson\u2019s disease therapy: targeting BCL-2","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioadv.2026.214822_bb1080","article-title":"Boosting neurite outgrowth and anti-oxidative stress for treatment of Parkinson\u2019s disease by biomimetic ultrasmall nanoparticles","volume":"39","author":"Yuan","year":"2024","journal-title":"Sustain. Mater. Technol."},{"key":"10.1016\/j.bioadv.2026.214822_bb1085","series-title":"In Silico and In Vivo Studies on Quercetin as Potential Anti-Parkinson Agent","first-page":"1","author":"Boyina","year":"2020"},{"issue":"52","key":"10.1016\/j.bioadv.2026.214822_bb1090","doi-asserted-by":"crossref","first-page":"21730","DOI":"10.1021\/jacs.0c09390","article-title":"Targeting microglia for therapy of Parkinson\u2019s disease by using biomimetic Ultrasmall nanoparticles","volume":"142","author":"Liu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214822_bb1095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10787-017-0402-8","article-title":"Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson\u2019s disease model","volume":"26","author":"Sharma","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214822_bb1100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/187152712800792785","article-title":"A synopsis on the role of tyrosine hydroxylase in Parkinson\u2019s disease","volume":"11","author":"Tabrez","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214822_bb1105","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/acscentsci.2c00741","article-title":"Brain-targeted biomimetic Nanodecoys with neuroprotective effects for precise therapy of Parkinson\u2019s disease","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"issue":"23","key":"10.1016\/j.bioadv.2026.214822_bb1110","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMct0800326","article-title":"Levodopa for the treatment of Parkinson\u2019s disease","volume":"359","author":"LeWitt","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2026.214822_bb1115","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.actbio.2024.01.019","article-title":"Biomimetic nanodecoys deliver cholesterol-modified heteroduplex oligonucleotide to target dopaminergic neurons for the treatment of Parkinson\u2019s disease","volume":"177","author":"Huang","year":"2024","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214822_bb1120","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acsbiomaterials.3c00146","article-title":"Biomimetic biomembrane encapsulation and targeted delivery of a nitric oxide release platform for therapy of Parkinson\u2019s disease","volume":"9","author":"Huang","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioadv.2026.214822_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.161251","article-title":"Microglial membrane-coated nanoparticles for ACSL4-siRNA delivery in Parkinson\u2019s disease","volume":"509","author":"Lu","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioadv.2026.214822_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123537","article-title":"Mesenchymal stem cell membrane camouflaged mesoporous polydopamine for Parkinson\u2019s disease treatment via alleviating oxidative stress mediated neuroinflammation","volume":"324","author":"Chen","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.214822_bb1135","article-title":"Enhanced neuroprotection in Parkinson\u2019s disease by neutrophil-biomimetic nanovesicles through autophagy inhibition and apoptosis antagonism","volume":"521","author":"Li","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"5","key":"10.1016\/j.bioadv.2026.214822_bb1140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052336","article-title":"Cell membrane biomimetic nanoparticles with potential in treatment of Alzheimer\u2019s disease","volume":"28","author":"Zhong","year":"2023","journal-title":"Molecules"},{"issue":"26","key":"10.1016\/j.bioadv.2026.214822_bb1145","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202402445","article-title":"Revolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes","volume":"36","author":"Liao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.214822_bb1150","article-title":"Exosome-mediated dual drug delivery of curcumin and methylene blue for enhanced cognitive function and mechanistic elucidation in Alzheimer\u2019s disease therapy","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:34:06Z","timestamp":1778934846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":230,"alternative-id":["S2772950826001202"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214822","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of cell membrane-coated nanoparticles in targeted therapy for brain disorders","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214822"}}